The latest version of the AJCC TNM staging system for cutaneous melanoma has been released (based on 30,946 cases). The main changes are the following: 1) mitotic rate (added); 2) Clark level (removed). The main limit is that, once again, no molecular biomarker has been implemented. The details of the new TNM staging system are available at the Melanoma Molecular Map Project (MMMP) website (http://www.mmmp.org/MMMP/import.mmmp?page=tnm_staging.mmmp).
If our reporting has informed or inspired you, please consider making a donation. Every contribution, no matter the size, empowers us to continue delivering accurate, engaging, and trustworthy science and medical news. Independent journalism requires time, effort, and resources—your support ensures we can keep uncovering the stories that matter most to you.
Join us in making knowledge accessible and impactful. Thank you for standing with us!